Drug intelligence / Profile preview

FAR IBD PLUS

Development stage: Unknown
Lead developer: FARVET
Modality: Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration: Oral, Ophthalmic

Overview

FAR IBD PLUS is a live attenuated lyophilized vaccine developed by FARVET for the prevention of Infectious Bursal Disease (IBD), also known as Gumboro Disease, in poultry. The vaccine utilizes the Lukert intermediate strain of the Infectious Bursal Disease Virus (IBDV). This strain is characterized as an "intermediate" strain, meaning it possesses a level of pathogenicity that allows it to break through maternal antibodies while remaining safe for the birds. The mechanism of action involves the replication of the attenuated virus in the host, stimulating both humoral and cellular immune responses against IBDV, specifically targeting the bursa of Fabricius to provide protection against field strains of the virus.

Brand names: FAR IBD PLUS
Other names: FAR IBD PLUS-FARVETInfectious Bursal Disease Virus (IBDV) Lukert intermediate strain vaccine

Beyond the preview

Go deeper on FAR IBD PLUS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FAR IBD PLUS.

Explore the full profile